{"id":"hydroxymethylquinoxalindioxyde","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Quinoxaline dioxides are known to possess antioxidant properties through their ability to neutralize reactive oxygen species and free radicals. The hydroxymethyl substitution may enhance bioavailability or target tissue penetration. This mechanism suggests potential utility in conditions characterized by oxidative stress pathology.","oneSentence":"Hydroxymethylquinoxalindioxyde is a quinoxaline derivative that likely acts as an antioxidant or free radical scavenger to reduce oxidative stress-related cellular damage.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:48:07.008Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT05561816","phase":"PHASE3","title":"Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma","status":"COMPLETED","sponsor":"Valenta Pharm JSC","startDate":"2022-07-19","conditions":"Pyoderma","enrollment":240},{"nctId":"NCT05505097","phase":"PHASE1","title":"Safety and Pharmacokinetics of Dioxidin, Solution for Topical and External Use, 0.25 mg/ml and Dioxidin, Solution for Infusion and External Use, 5 mg/ml in Healthy Volunteers","status":"COMPLETED","sponsor":"Valenta Pharm JSC","startDate":"2022-05-04","conditions":"Infections","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Dioxidin"],"phase":"phase_3","status":"active","brandName":"Hydroxymethylquinoxalindioxyde","genericName":"Hydroxymethylquinoxalindioxyde","companyName":"Valenta Pharm JSC","companyId":"valenta-pharm-jsc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}